Rocket


News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

GH Research PLC Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"P.0411 0.015 0.020 0.010 0.005 0.000"
09/29/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression"
08/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Unaudited Condensed Consolidated Interim Financial Statements for the three and six months ended June 30, 2023",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations",
"Condensed Consolidated Interim Statement of Comprehensive Income Three months ended June 30, Six months ended June 30, 2023 $’000 2022 $’000 2023 $’000 2022 $’000",
"Corporate Presentation for August 2023"
07/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Notice of Annual General Meeting",
"Directors’ Report and 2022 Irish Statutory Financial Statements",
"Annual General Meeting Notice Regarding Agenda",
"Annual General Meeting Notice Regarding the Availability of Proxy Materials",
"Annual General Meeting Proxy Card (Record Holders)",
"Annual General Meeting Proxy Card (Brokers)"
05/25/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Unaudited Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2023",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations",
"Condensed Consolidated Interim Statement of Comprehensive Income Three months ended March 31, 2023 2022 $’000 $’000",
"Corporate Presentation for May 2023"
03/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
03/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"(15,100",
"Corporate Presentation for March 2023"
01/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"GH Research Provides Business Updates and Highlights Key Upcoming Milestones",
"Corporate Presentation for January 2023"
10/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Poster for a Phase 1/2 clinical trial of GH001 (GH001-TRD-102), for October 2022",
"Presentation for a Phase 1/2 clinical trial of GH001 (GH001-TRD-102), for October 2022",
"Poster for a Phase 1 clinical trial of GH001 (GH001-HV-101), for October 2022",
"Presentation for a Phase 1 clinical trial of GH001 (GH001-HV-101), for October 2022"
09/22/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
09/21/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Presentation for September 2022",
"Poster for September 2022"
09/16/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
09/08/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
08/23/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Unaudited Condensed Consolidated Interim Financial Statements for the three and six months ended June 30, 2022",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations",
"Dublin, Ireland, August 23, 2022"
08/11/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Notice of Annual General Meeting",
"Directors’ Report and 2021 Irish Statutory Financial Statements",
"Annual General Meeting Notice Regarding Agenda",
"Annual General Meeting Notice Regarding the Availability of Proxy Materials",
"Annual General Meeting Proxy Card (Record Holders)",
"Annual General Meeting Proxy Card (Brokers)"
06/24/2022 6-K Quarterly results
05/31/2022 6-K Quarterly results
05/18/2022 6-K Quarterly results
05/18/2022 6-K Quarterly results
03/28/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Dublin, Ireland, March 28, 2022 – GH Research PLC , a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the full year ended December 31, 2021 and gave updates on its business. Fourth Quarter 2021 Business Highlights In December 2021, we reported the successful outcome of the Phase 2 part of our Phase 1/2 clinical trial of GH001, our proprietary inhalable 5-methoxy-N,N-dimethyltryptamine product candidate, in patients with treatment-resistant depression . The primary endpoint of the Phase 2 part of the trial was met with 7 of 8 patients in remission ≤10) at day 7 after dosing , which supported the safety profile of GH001 single doses and the proprietary GH001 IDR with up to t...",
"Corporate Presentation"
03/25/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/04/2022 6-K Quarterly results
12/06/2021 6-K Quarterly results
12/06/2021 6-K Quarterly results
11/22/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "PricewaterhouseCoopers SA letter to the SEC",
"PricewaterhouseCoopers SA letter to the SEC"
11/05/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
10/26/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Corporate Presentation for October 2021",
"Corporate Presentation for October 2021"
09/23/2021 6-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy